#glenmark ipo

[transfin1]

Glenmark Life Sciences IPO - Why It May Not Be the Best Buy

The IPO of API manufacturer Glenmark Life Sciences is scheduled to hit the markets on July 27th, marking this year’s 29th public offering.

The company was spun off as a wholly-owned API business subsidiary of Glenmark Pharmaceuticals in 2018.

Even though it has been doing some good business owing to rising market and policy winds favouring generics and patent liberation, this IPO may not have come at a particularly good time, in light of Glenmark Life’s financial obligation to its parent.

Read more on why this IPO may or may not be a good buy by clicking on the link below.

https://transfin.in/glenmark-life-sciences-ipo-why-it-may-not-be-the-best-buy

[thinkwithlogic]

Glenmark Life Sciences Limited IPO-Details, Lot Size, Price Band, Date, GMP & Review

Glenmark Life Sciences Limited IPO-Details, Lot Size, Price Band, Date, GMP & Review

Brief History of Company Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further…

View On WordPress

[dbpnews]

List of Upcoming IPOs in July: Zomato, Shriram Properties and Others

List of Upcoming IPOs in July: Zomato, Shriram Properties and Others

July is looking to be a month of many public offerings as the IPO market is looking quite saturated as 12 different companies are setting the stage to launch their public issues. Following the second COVID-19 wave, Indian companies raised around Rs 40,000 crores in the first half of 2021, as opposed to the Rs 20,000 that was raised in the second half of 2020. This was spread out over a two-month…

View On WordPress